Miriam Schmid MBA is a seasoned professional in strategic portfolio management and clinical development, serving as Senior Director of Strategic Portfolio Management at CureVac since March 2024. Additionally, Miriam holds a volunteer position in corporate relations for the Western Europe Region of the Healthcare Businesswomen's Association since October 2023. With extensive experience at Merck Gruppe from May 2017 to December 2022, Miriam led a global team in portfolio management and served as Director of Financial Planning and Analysis. Prior roles include Clinical Program Director at UCB, Senior Clinical Project Manager at Schwarz Pharma, and a range of positions in clinical trial management. Miriam's academic credentials include dual executive MBAs from Rotterdam School of Management and University of Cologne Business School, complemented by a Master’s in Human Nutrition from Justus Liebig University Giessen.
This person is not in any teams
This person is not in any offices